What Is Medication-Assisted Treatment for Opioid Addiction?

Checkmark Icon Medically Reviewed

More Time. More Joy. More You. Start Now.

WE ACCEPT MOST INSURANCES

Last Updated on October 1, 2026

Medication-assisted treatment (MAT) is an evidence-based approach that combines FDA-approved medications with behavioral therapy and counseling to treat opioid use disorder. MAT helps manage withdrawal symptoms, reduce cravings, and normalize brain chemistry disrupted by chronic opioid use, allowing patients to engage fully in therapy and rebuild their lives. The medications used—primarily buprenorphine, methadone, and naltrexone—work on the same opioid receptors affected by heroin, fentanyl, and prescription painkillers, but without producing euphoria or dangerous side effects when taken as prescribed.

If you or someone you love needs more than detox, Nova Recovery Center also provides inpatient rehab austin.

Nova Recovery Center’s substance abuse treatment program provides medically supervised, evidence-based care.

How Medication-Assisted Treatment Helps With Opioid Addiction Recovery

Opioid addiction creates profound changes in brain chemistry, particularly in reward pathways and stress response systems. When someone stops using opioids abruptly, withdrawal symptoms can be severe enough to derail even the most motivated attempts at recovery. MAT addresses this biological reality directly.

The medications used in MAT occupy opioid receptors in the brain, preventing withdrawal and eliminating the intense physical cravings that drive relapse. This stabilization gives patients the mental and physical space to participate in counseling, process trauma, learn coping skills, and address the underlying issues that contributed to their substance use. Without the constant distraction of cravings and the fear of withdrawal, recovery becomes possible.

Research consistently shows that medication-assisted treatment improves retention in treatment programs, reduces illicit opioid use, decreases overdose deaths, and helps patients return to work and family responsibilities. It is not replacing one addiction with another—it is correcting a medical condition with appropriate medical treatment.

FDA-Approved Medications Used in Opioid Addiction Treatment

Three primary medications form the foundation of medication-assisted treatment for opioid use disorder. Each works differently and suits different clinical scenarios.

Buprenorphine is a partial opioid agonist, meaning it activates opioid receptors but only partially, producing a ceiling effect that prevents overdose and euphoria. It effectively relieves withdrawal symptoms and cravings while carrying a lower risk of misuse. Buprenorphine can be prescribed in office-based settings, making it accessible through outpatient treatment programs. Common formulations include Suboxone (buprenorphine combined with naloxone) and Sublocade (a monthly injection).

Methadone is a full opioid agonist that has been used in addiction treatment for decades. It eliminates withdrawal symptoms and blocks the euphoric effects of other opioids. Methadone must be dispensed through specially licensed clinics with daily observed dosing during the initial treatment phase. It remains highly effective for patients with severe, long-standing opioid dependence.

Naltrexone is an opioid antagonist that blocks opioid receptors entirely, preventing any opioid from producing effects. It does not relieve cravings or withdrawal, so patients must complete detoxification before starting naltrexone. The extended-release injectable form (Vivitrol) is given monthly and is particularly useful for patients who have already achieved initial abstinence and want additional protection against relapse.

What Happens During Medication-Assisted Treatment

Medication-assisted treatment is not simply taking a pill. It is a comprehensive treatment approach that integrates medical management with psychosocial support.

Treatment begins with a thorough assessment by medical and clinical staff. A physician evaluates the patient’s opioid use history, physical health, co-occurring mental health conditions, previous treatment attempts, and current withdrawal status. This assessment determines which medication is most appropriate and at what dose to begin.

Once medication is initiated, patients engage in individual counseling, group therapy, and other evidence-based behavioral interventions. Counseling addresses the psychological aspects of addiction—trauma, co-occurring disorders, relationship problems, employment challenges, and relapse prevention strategies. The medication creates the stability needed for this therapeutic work to be effective.

Medical monitoring continues throughout treatment. Physicians adjust medication dosages based on symptom relief, side effects, and ongoing substance use. Urine drug screens help track progress and identify any return to use early. The treatment team collaborates to support the patient’s goals and adjust the treatment plan as needed.

Medication-Assisted Treatment in Different Levels of Care

MAT can be delivered across the continuum of addiction treatment, from residential programs to outpatient care. The level of care depends on the severity of the addiction, the presence of co-occurring disorders, and the patient’s social stability.

Residential treatment provides 24-hour care in a structured environment where patients can be safely inducted onto medication, stabilized, and begin intensive therapy. This setting is ideal for patients with severe opioid dependence, co-occurring medical or psychiatric conditions, or unstable living situations. Nova Recovery Center’s residential programs in Austin and Wimberley, Texas, offer medically supervised MAT initiation alongside comprehensive behavioral health treatment.

Outpatient programs allow patients to live at home while attending scheduled treatment sessions. Intensive outpatient programs (IOP) typically involve nine or more hours of therapy per week, while standard outpatient care may involve one to two sessions weekly. Outpatient MAT works well for patients who have completed residential care or who have sufficient stability to manage recovery while maintaining work and family responsibilities. Nova Recovery Center offers outpatient addiction treatment with medication-assisted treatment in Austin, Houston, and San Antonio, Texas, as well as Colorado Springs, Colorado.

Telehealth options have expanded access to MAT significantly. Federal regulations now permit buprenorphine to be prescribed via telemedicine without an initial in-person visit, making treatment available to patients in rural areas or those with transportation barriers. Nova’s online intensive outpatient program delivers evidence-based care, including MAT coordination, to patients regardless of location.

Addressing Common Concerns About Medication-Assisted Treatment

Despite strong evidence supporting MAT, misconceptions persist. Some people worry that using medication to treat opioid addiction is simply replacing one drug with another. This misunderstands both addiction and treatment.

Addiction is a chronic medical condition involving changes to brain structure and function. MAT medications correct the neurochemical imbalances created by chronic opioid use, much like insulin treats diabetes or antidepressants treat depression. When used as prescribed under medical supervision, these medications allow the brain to heal while the patient rebuilds their life.

Another concern is dependence on MAT medications. Yes, the body becomes physically dependent on buprenorphine or methadone, just as it depends on blood pressure medication or thyroid hormone replacement. But dependence is not addiction. Addiction involves compulsive use despite harm, loss of control, and continued use despite negative consequences. MAT medications, taken as prescribed, restore function and improve quality of life.

Duration of treatment is individualized. Some patients benefit from MAT for months, others for years, and some choose to remain on medication indefinitely. Research shows that longer treatment durations produce better outcomes. Tapering off medication should be done slowly, under medical supervision, and only when the patient has achieved sustained stability.

The Role of Counseling and Behavioral Therapy

Medication addresses the neurobiological components of opioid addiction, but recovery requires more than symptom management. Counseling and behavioral therapy are essential components of medication-assisted treatment.

Cognitive-behavioral therapy (CBT) helps patients identify and change thought patterns and behaviors that contribute to substance use. Patients learn to recognize triggers, develop coping strategies, and build skills for managing cravings and stress without returning to opioid use.

Trauma-informed care addresses the high rates of trauma among people with opioid use disorder. Many patients have experienced physical or sexual abuse, neglect, violence, or loss. Processing these experiences in a safe therapeutic environment reduces their power to drive addictive behavior.

Group therapy provides peer support, reduces isolation, and allows patients to learn from others facing similar challenges. Family therapy helps repair relationships damaged by addiction and educates loved ones about recovery, creating a supportive home environment.

Insurance Coverage and Payment for Medication-Assisted Treatment

Most insurance plans, including commercial insurance, Medicaid, and Medicare, cover medication-assisted treatment for opioid use disorder. The Mental Health Parity and Addiction Equity Act requires insurers to cover substance use disorder treatment at the same level as other medical conditions.

Coverage typically includes the medication itself, physician visits for medication management, counseling and therapy sessions, and drug screening. Prior authorization may be required for certain medications or levels of care. Nova Recovery Center’s admissions team verifies insurance benefits before admission and helps patients understand their coverage, out-of-pocket costs, and payment options.

For patients without insurance or with limited coverage, payment plans and financing options may be available. The investment in evidence-based treatment pays long-term dividends in health, relationships, employment, and quality of life.

Get Help With Opioid Addiction Recovery

Medication-assisted treatment represents the current standard of care for opioid use disorder, supported by decades of research and clinical experience. If you or someone you care about is struggling with opioid addiction, Nova Recovery Center offers comprehensive MAT programs integrated with evidence-based therapy across our residential and outpatient locations. Reach out today to verify your insurance benefits and learn how we can help.

Ready to take the next step?

Nova Recovery Center provides inpatient and outpatient drug & alcohol rehab. Call (512) 893-6955 to speak with our team today.

Frequently Asked Questions

What is the newest treatment for opioid addiction?
The newest FDA-approved treatment is Sublocade, a monthly buprenorphine injection introduced in 2018. Long-acting injectable buprenorphine eliminates daily dosing and improves medication adherence. Additionally, telehealth delivery of medication-assisted treatment has expanded dramatically since 2020, making evidence-based care more accessible. However, the core medications—buprenorphine, methadone, and naltrexone—remain the foundation of effective opioid addiction treatment, supported by decades of research.
What is a unique benefit of medication-assisted treatment for opioid use?
MAT uniquely addresses both the biological and psychological aspects of opioid addiction simultaneously. The medication stabilizes brain chemistry, eliminates withdrawal symptoms, and reduces cravings, creating the neurological stability needed for patients to fully engage in counseling and therapy. This integrated approach produces significantly better retention rates and outcomes than behavioral therapy or medication alone, making sustained recovery achievable for patients with severe opioid dependence.
How do people recover from opioid addiction?
Recovery from opioid addiction typically requires a combination of medical treatment, behavioral therapy, and ongoing support. Most successful recoveries involve medication-assisted treatment to manage withdrawal and cravings, individual and group counseling to address underlying issues, and participation in recovery support communities. Treatment may begin in residential rehab or intensive outpatient programs, followed by continuing care. Recovery is a long-term process that often requires multiple levels of care and sustained engagement.
What are some drugs used to treat withdrawal symptoms?
Buprenorphine is the most commonly used medication for treating opioid withdrawal symptoms. It relieves discomfort, reduces cravings, and can be prescribed in outpatient settings. Methadone is also highly effective for withdrawal management and long-term maintenance. Clonidine and other supportive medications may be used to manage specific symptoms like anxiety, insomnia, or muscle aches. For severe cases, medically supervised detoxification in a residential setting provides the safest environment for withdrawal management.
Which drug has the longest withdrawal?
Methadone and other long-acting opioids typically produce the longest withdrawal timelines, with acute symptoms lasting two to three weeks and post-acute withdrawal symptoms persisting for months. Benzodiazepines also have protracted withdrawal periods. However, withdrawal severity and duration depend on many factors including dose, duration of use, individual metabolism, and whether medications are used to manage symptoms. Medically supervised withdrawal with medication-assisted treatment significantly reduces discomfort and improves success rates.
Which drug is used for opioid withdrawal management?
Buprenorphine is the primary medication used for opioid withdrawal management and ongoing treatment. As a partial opioid agonist, it relieves withdrawal symptoms without producing euphoria. Methadone is also used, particularly for severe dependence. Naltrexone can be started after detoxification is complete to prevent relapse. Clonidine and other symptomatic medications may supplement these primary treatments. The choice depends on the patient's clinical presentation, treatment setting, and individual needs.
What are the hardest addictions to quit?
Opioid addiction is among the most difficult to quit without professional help due to severe withdrawal symptoms, intense cravings, and profound changes to brain reward systems. Alcohol and benzodiazepine withdrawal can be medically dangerous and require supervised detoxification. Methamphetamine addiction produces long-lasting changes to dopamine systems. However, with evidence-based treatment including medication-assisted treatment for opioids, professional counseling, and ongoing support, recovery from even the most severe addictions is achievable.
How long do opioid withdrawals last?
Acute opioid withdrawal symptoms typically begin six to twelve hours after the last use of short-acting opioids like heroin and peak at two to three days. Physical symptoms generally resolve within five to ten days. Long-acting opioids like methadone have a delayed onset and longer duration. Post-acute withdrawal symptoms including sleep disturbances, mood changes, and cravings can persist for weeks or months. Medication-assisted treatment significantly reduces withdrawal severity and duration.

VERIFY YOUR INSURANCE TODAY! (FREE & CONFIDENTIAL)

=
Dr. Robert Ulrich

Dr. Robert Ulrich

Medical Director | Nova Recovery Center

Dr. Robert Ulrich serves as Medical Director at Nova Recovery Center, bringing more than two decades of clinical neurology experience to the treatment of substance use disorders. He is board-certified in neurology by the American Board of Psychiatry and Neurology and completed his neurology residency at UT Southwestern Medical Center in Dallas, where he served as Chief Resident.

Throughout his career in neurology, Dr. Ulrich observed that many patients with neurological conditions also faced challenges related to substance use. In late 2022, he shifted his clinical focus toward addiction medicine, applying his extensive knowledge of brain function, neurochemistry, and the central nervous system to support individuals in recovery.

As Medical Director, Dr. Ulrich provides clinical leadership and helps guide the medical services delivered at Nova Recovery Center. His background in neurology allows him to approach addiction treatment with a detailed understanding of the neurological, physical, and behavioral factors that influence substance use and recovery.

Dr. Ulrich works closely with the clinical team to support individualized, evidence-based treatment plans designed to promote patient safety, stability, and long-term recovery.

Anna-Grace Washington

Medical Content Strategist

Anna-Grace Washington is a Medical Content Writer for Nova Recovery Center. She holds a master’s degree in clinical psychology from the University of Texas and brings a strong understanding of behavioral health, addiction recovery, and evidence-based treatment concepts to her writing. Through her work, Anna-Grace helps create clear, accurate, and compassionate content for individuals and families seeking information about substance use disorders, mental health, and long-term recovery. Her writing reflects Nova Recovery Center’s commitment to education, support, and clinically informed care.
Call Now Button